You are here Home Resources Handbook tables Handbook tables Table. Recommendations for meningococcal vaccines for healthy people aged ≥2 years, by age and vaccine brand Listen Print Share Twitter Facebook Email Age at start of vaccine course Vaccine type Vaccine brand Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease) 2–9 years MenACWY Preferably Menveo or Nimenrix, otherwise Menactra 1 dose MenB Bexsero 2 doses (8 weeks between doses) ≥10 years MenACWYa Preferably Menveo or Nimenrix, otherwise Menactra 1 dose MenB Bexsero 2 doses (8 weeks between doses) MenB Trumenba 2 doses (6 months between doses) MenACWYa- aThere is no registered upper age limit for use of Menveo and Nimenrix. Although Menactra is registered for use up to 55 years of age only, it can be given to people >55 years of age. Page history Last updated 5 June 2018 Last reviewed 5 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank